Anthera Pharmaceuticals Inc (ANTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Operating Expenses | 28,429 | 23,370 | 22,682 | 18,657 | 12,949 |
| Operating Income | -28,429 | -23,370 | -22,682 | -18,657 | -12,949 |
| Interest Expense | 912 | 920 | 902 | 69 | 0 |
| Other Income | -3,553 | -153 | 414 | 160 | -91 |
| Pre-tax Income | -32,894 | -24,443 | -23,170 | -18,566 | -13,040 |
| Net Income Continuous | -32,894 | -24,443 | -23,170 | -18,566 | -13,040 |
| Net Income | $-32,894 | $-24,443 | $-23,170 | $-18,566 | $-13,040 |
| EPS Basic Total Ops | -52.96 | -38.40 | -42.24 | -35.84 | -13.44 |
| EPS Basic Continuous Ops | -52.54 | -38.31 | -42.49 | -36.12 | -13.56 |
| EPS Diluted Total Ops | -52.96 | -38.40 | -42.24 | -35.84 | -13.44 |
| EPS Diluted Continuous Ops | -52.54 | -38.31 | -42.49 | -36.12 | -13.56 |
| EBITDA(a) | $-28,123 | $-23,122 | $-22,431 | $-18,560 | $-12,843 |